Juno Therapeutics Plunges 30% After 2 Patient Deaths From Lead Cancer Drug By: Benzinga via Benzinga July 07, 2016 at 16:36 PM EDT Juno Therapeutics Inc (NASDAQ: JUNO) was halted shortly after Thursday's closing bell. A couple minutes later, the company ... Read More >> Related Stocks: S&P Biotech SPDR